These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34754108)

  • 21. Pharmacogenetics to Avoid Adverse Reactions in Cardiology: Ready for Implementation?
    García-González X; Salvador-Martín S
    J Pers Med; 2021 Nov; 11(11):. PubMed ID: 34834533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacogenetics of psychotropic drug response.
    Malhotra AK; Murphy GM; Kennedy JL
    Am J Psychiatry; 2004 May; 161(5):780-96. PubMed ID: 15121641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progress and prospects in pharmacogenetics of antidepressant drugs.
    Fabbri C; Crisafulli C; Calabrò M; Spina E; Serretti A
    Expert Opin Drug Metab Toxicol; 2016 Oct; 12(10):1157-68. PubMed ID: 27310483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacogenetic studies: a tool to improve antidepressant therapy.
    Ramos M; Berrogain C; Concha J; Lomba L; García CB; Ribate MP
    Drug Metab Pers Ther; 2016 Dec; 31(4):197-204. PubMed ID: 27889704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response.
    Kirchheiner J; Nickchen K; Bauer M; Wong ML; Licinio J; Roots I; Brockmöller J
    Mol Psychiatry; 2004 May; 9(5):442-73. PubMed ID: 15037866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real-world determinants of adjunctive antipsychotic prescribing for patients with major depressive disorder and inadequate response to antidepressants: a case review study.
    McIntyre RS; Weiller E
    Adv Ther; 2015 May; 32(5):429-44. PubMed ID: 25968482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacogenetics in psychiatry: state of the art].
    Müller DJ; Brandl EJ; Degenhardt F; Domschke K; Grabe H; Gruber O; Hebebrand J; Maier W; Menke A; Riemenschneider M; Rietschel M; Rujescu D; Schulze TG; Tebartz van Elst L; Tüscher O; Deckert J;
    Nervenarzt; 2018 Mar; 89(3):290-299. PubMed ID: 29383410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacogenetics of antidepressant drugs: State of the art and clinical implementation - recommendations from the French National Network of Pharmacogenetics.
    Quaranta S; Dupouey J; Colle R; Verstuyft C
    Therapie; 2017 Apr; 72(2):311-318. PubMed ID: 28237405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in prescription of psychotropic medications to children and adolescents in Australian primary care from 2011 to 2018.
    Klau J; Bernardo CO; Gonzalez-Chica DA; Raven M; Jureidini J
    Aust N Z J Psychiatry; 2022 Nov; 56(11):1477-1490. PubMed ID: 34963342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenetic methods as a complement to therapeutic monitoring of antidepressants and neuroleptics.
    Dahl ML; Sjöqvist F
    Ther Drug Monit; 2000 Feb; 22(1):114-7. PubMed ID: 10688272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacogenetics of antipsychotic therapy: pivotal research issues and the prospects for clinical implementation.
    Lerer B; Segman RH
    Dialogues Clin Neurosci; 2006; 8(1):85-94. PubMed ID: 16640118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacogenetics of antipsychotics: recent progress and methodological issues.
    Zhang JP; Malhotra AK
    Expert Opin Drug Metab Toxicol; 2013 Feb; 9(2):183-91. PubMed ID: 23199282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unveiling the guidance heterogeneity for genome-informed drug treatment interventions among regulatory bodies and research consortia.
    Koutsilieri S; Tzioufa F; Sismanoglou DC; Patrinos GP
    Pharmacol Res; 2020 Mar; 153():104590. PubMed ID: 31830522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacogenomics in schizophrenia: the quest for individualized therapy.
    Basile VS; Masellis M; Potkin SG; Kennedy JL
    Hum Mol Genet; 2002 Oct; 11(20):2517-30. PubMed ID: 12351588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenetics of antidepressant drugs: an update after almost 20 years of research.
    Fabbri C; Di Girolamo G; Serretti A
    Am J Med Genet B Neuropsychiatr Genet; 2013 Sep; 162B(6):487-520. PubMed ID: 23852853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Personalised pharmacogenetics. Evidence-based guidelines and clinical application of pharmacogenetic diagnostics].
    Stingl JC; Brockmöller J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1509-21. PubMed ID: 24170080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacogenetics Guidelines: Overview and Comparison of the DPWG, CPIC, CPNDS, and RNPGx Guidelines.
    Abdullah-Koolmees H; van Keulen AM; Nijenhuis M; Deneer VHM
    Front Pharmacol; 2020; 11():595219. PubMed ID: 33568995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence and resources to implement pharmacogenetic knowledge for precision medicine.
    Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE
    Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Perspectives of the use of pharmacogenetic tests in neurology and psychiatry].
    Kostyuk GP; Zakharova NV; Reznik AM; Surkova EI; Ilinsky VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(9):131-135. PubMed ID: 31626230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological treatment for psychotic depression.
    Wijkstra J; Lijmer J; Burger H; Cipriani A; Geddes J; Nolen WA
    Cochrane Database Syst Rev; 2015 Jul; (7):CD004044. PubMed ID: 26225902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.